Amplify Weight Loss Drug & Treatment ETF (THNR)
| Assets | $5.09M |
| Expense Ratio | 0.59% |
| PE Ratio | 17.85 |
| Shares Out | 200,000 |
| Dividend (ttm) | $0.41 |
| Dividend Yield | 1.60% |
| Ex-Dividend Date | Dec 30, 2025 |
| Payout Frequency | Annual |
| Payout Ratio | 28.56% |
| Volume | 572 |
| Open | 25.77 |
| Previous Close | 25.75 |
| Day's Range | 25.75 - 26.07 |
| 52-Week Low | 21.70 |
| 52-Week High | 27.28 |
| Beta | 0.38 |
| Holdings | 23 |
| Inception Date | May 21, 2024 |
About THNR
Fund Home PageThe Amplify Weight Loss Drug & Treatment ETF (THNR) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a modified market cap-weighted index of companies from developed markets that manufacture and enable GLP-1 agonist pharmaceutical businesses. THNR was launched on May 21, 2024 and is issued by Amplify Investments.
Top 10 Holdings
61.20% of assets| Name | Symbol | Weight |
|---|---|---|
| Novo Nordisk A/S | NVO | 9.95% |
| Eli Lilly and Company | LLY | 9.21% |
| Innovent Biologics, Inc. | 1801 | 5.49% |
| CSPC Pharmaceutical Group Limited | 1093 | 5.45% |
| AbbVie Inc. | ABBV | 5.37% |
| Arrowhead Pharmaceuticals, Inc. | ARWR | 5.35% |
| Regeneron Pharmaceuticals, Inc. | REGN | 5.14% |
| Roche Holding AG | ROP | 5.12% |
| Amgen Inc. | AMGN | 5.08% |
| Merck & Co., Inc. | MRK | 5.05% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 30, 2025 | $0.41317 | Dec 31, 2025 |
| Dec 30, 2024 | $0.2199 | Dec 31, 2024 |
Performance
THNR had a total return of 9.74% in the past year, including dividends. Since the fund's inception, the average annual return has been 1.77%.
News
Inside THNR: A Leaner Approach to Weight Loss Investing
Demand for GLP-1 weight loss drugs has reshaped the healthcare industry. And ETFs such as the Amplify Weight Loss Drug & Treatment ETF (THNR) give investors a way to access this growing market.
Healthcare ETFs: From Broad Exposure to Big Breakthroughs
With AI and space dominating many of the market's most popular investment themes, it can be difficult to find differentiated opportunities. Healthcare is often viewed as one of the more defensive sect...
SILJ, HACK, THNR: Trends in Thematic Investing
Amplify Junior Silver Miners ETF (SILJ) is up 28% year-to-date. Christian Magoon discusses the outlook for cybersecurity stocks, as Amplify's Cybersecurity ETF (HACK) is up 8% year-to-date.
Why Investors Haven't Feasted on Two New Weight-Loss ETFs
Two new weight-loss exchange-traded funds (ETFs) launched in May have yet to whet investors' appetite, possibly due to their expensive fees and concentrated bets.